Hello tutors, be detailed and give professional answers.

Business law case study, The case examines the viability of providing insurance cover for intangible assets. It also throws light on the difficulty of underwriting risks for intangible assets because of the lack of historical data. Issues associated with the provision of insurance against the infringement of Intellectual Property Rights (IPRs) are also discussed in the case. In addition, problems that impede the development of products, which provide insurance cover against the infringement of IPRs are also addressed.

11 What does BM mean in relation to blood sugar monitoring?

12 What is the role of urine examination in diabetic control?

13 Diabetes and diet: could the authors of my favourite medical text please advise whether or not it is acceptable to have controlled quantities of refined sugar, providing the total calorie intake is kept under control?

14 Do non-obese patients with impaired fasting glucose, i.e. a glucose level of 6.1-6.9 mmol/L, need drug treatment with biguanides if lifestyle modifications fail to normalize?

15 Do non-obese patients with impaired glucose tolerance (but not fulfilling the criteria for diabetes mellitus) need drug treatment with biguanides if lifestyle modifications fail to normalize their post-prandial blood glucose measurements?

16 It is the Muslim month of fasting currently. I would be grateful if you could advise on how to adjust the insulin regimen of a type 1 diabetic patient, for example a 21-year-old girl who is on subcutaneous Actrapid (short-acting soluble insulin) 22 units t.d.s.

17 I would like to know more about the use of the glitazone group in type 2 diabetes: its action, side-effects, precautions taken on using them.

18 In a patient receiving oral antidiabetics, should the drug be administered just after taking the blood sample for fasting blood glucose level (and before a meal), or just prior to the sample being taken?

19 What oral antidiabetics are safe in pregnancy?

20 Is it necessary to put all type 2 diabetics on aspirin?